Table 1 Baseline data table of 374 patients with ESCC
Parameters | Center 1 (n = 251) | Center 2 (n = 123) | P |
|---|---|---|---|
Age | 66.76 ± 10.11 | 67.51 ± 10.73 | 0.622 |
Sex (Male/Female) | 184/67 | 92/31 | 0.894 |
Tumor Location | Â | Â | 0.975 |
 upper | 67 (26.7%) | 34 (27.6%) |  |
 middle | 121 (48.2%) | 62 (50.4%) |  |
 lower | 63 (25.1%) | 27 (22.0%) |  |
T Stage (T1/T2) | 103/148 | 51/71 | 0.843 |
Lymph node metastasis | 87 (34.7%) | 42 (34.1%) | 0.966 |
Carcinoembryonic antigen (ng/ml) | 4.26 (1.91, 5.24) | 4.73 (1.71, 6.02) | 0.218 |
Squamous cell carcinoma antigen (ng/ml) | 2.51 (0.43, 6.20) | 2.39 (0.47, 5.11) | 0.303 |
Neutrophil (×109/L) | 3.78 (2.95, 4.49) | 3.69 (2.88, 4.86) | 0.737 |
Monocyte (×109/L) | 0.37 (0.31, 0.47) | 0.41 (0.32, 0.49) | 0.652 |
Lymphocyte (×109/L) | 1.53 (1.32, 2.26) | 1.67 (1.30, 2.11) | 0.141 |
Platelet (×109/L) | 214 (200, 292) | 219 (195, 284) | 0.295 |
Haemoglobin (g/L) | 134 (107, 148) | 128 (112, 139) | 0.133 |
Albumin (g/L) | 42.47 (41.35, 45.03) | 43.31 (40.05, 46.53) | 0.422 |
Neutrophil to lymphocyte ratio | 2.36 (1.47, 2.79) | 2.27 (1.66, 2.65) | 0.377 |
Platelet to lymphocyte ratio | 133.54 (107.67, 188.27) | 128.35 (98.74, 172.97) | 0.149 |
Monocyte to lymphocyte ratio | 0.23 (0.19, 0.28) | 0.23 (0.18, 0.27) | 0.974 |
Systemic inflammatory response index | 0.87 (0.55, 1.18) | 0.79 (0.57, 1.12) | 0.635 |
Aggregate index of systemic inflammation | 182.83 (111.79, 287.65) | 177.62 (119.33, 266.51) | 0.782 |
Prognostic nutritional index | 50.44 (46.95, 54.33) | 43.74 (40.07, 52.13) | 0.074 |
